Closing the gaps in the access to quality-assured medicines for global health: The case for oxytocin for postpartum haemorrhage

This is the authors' abstract. We don't add key points for this paper.

Robust partnerships between stakeholders, to streamline medicine development and regulatory approval, are essential to close access gaps and ultimately prevent unnecessary deaths due to PPH in LMICs.